All News

The Food and Drug Administration’s approval of Turalio for tenosynovial giant cell tumors may offer significantly improved clinical benefit for select patients with these rare, benign tumors.

The first gluteal implant case has raised concern for risk of anaplastic large cell lymphoma in more than just textured breast implants.

A guy with a rare form of cancer ponders the significance of being obscure.

Immunotherapies and targeted therapies may cause skin, nail, hair and foot reactions that could reduce patient quality of life.

A cancer diagnosis can take so much from a person. Perhaps it can give a little something too. Cancer can open up our eyes to finding the time we never knew we had to do the things we always wanted to do.

Cancer can help us metamorphose into a beautiful new creature like the butterfly – stronger and more positive than before.

A slower walking pace among older adults with blood cancer can be a sign of frailty – which could be useful to know when tailoring one’s care to increase survival and lower hospitalizations.

Longer-term cancer survivor shares strategies to cope with the appointments, tests, and results that always seem to be looming on the horizon.

The Food and Drug Administration approved Turalio to treat patients diagnosed with a group of rare, benign tumors.

As a cancer survivor, there are times when you're consumed by guilt. Why did you make it to remission when others have lost their cancer battle?

Figuring out whether to take targeted drugs or immunotherapy can be challenging for patients with metastatic melanoma that expresses a BRAF gene mutation, but there are rules of thumb that can help.

After a cancer diagnosis, a person's identity may change. Often, one may choose to identify with familiar cancer terminology such as "patient," "survivor," or even "victim." These identities can form a lasting positive or negative impact on a person's life.

A lymphoma expert discusses implant removal, reconstruction and the signs of anaplastic large cell lymphoma.

Here are the top 5 CURE stories for July 2019.

The earlier lung cancer is detected, the better chance a person has of surviving the disease. Knowing the risk factors and statistics will help you to understand how you can minimize your possibility of developing the disease.

Following the Food and Drug Administration’s approval of Nubeqa, men with non-metastatic castration-resistant prostate cancer now have an earlier more precise treatment option.

Those of us who live with cancer don't just hope for the good reports, clear scans or positive lab results.

We may be halfway through the summer, but our #CURESummerSnacktime series is just heating up – or cooling down – with this week’s recipe for Dark Chocolate Frozen Banana Bites!

The Food and Drug Administration has approved Keytruda for recurrent locally advanced or metastatic squamous cell carcinoma of the esophagus in certain patients.

The Food and Drug Administration granted a priority review to Nubeqa for the treatment of men with non-metastatic castration-resistant prostate cancer.

Here is a list of the recent trial initiations that occurred within the cancer space in July.

Losing both my parents when I was so young led me to what would become my life’s purpose. Advocating for patients with cancer became my motivation and my mission.

Is it possible to be addicted to the anxiety cancer brings? I have been living with that addiction for years but have three ways to combat an anxiety addiction.

CURE® spoke with one expert about the various treatment options and current clinical trials available to patients with mesothelioma, as well as what they have to look forward to in the future.

Since my diagnosis I have gone out of my way to enjoy life in any way possible.

A beloved tradition at a local hospital disappears.

From landmark Senate legislation to the Pink Lemonade Stand Challenge, here’s what is making headlines in the cancer space this week.

CURE spoke with one expert about mesothelioma symptoms that patients can be on the lookout for, as well as how to be knowledgeable about certain risk factors.